Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924416 · ClinicalTrials.gov registry record · NA
Lung Cancer Information Study (LCIS-R01)
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT01924416 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 196 participants.
The verdict
NCT01924416, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
The primary specific aim is to test the hypothesis that use of a decision aid to enhance informed, shared decision making coupled with quality of life assessment in patients with advanced lung cancer receiving first-, second-, or third-line therapy will lead to a reduction in two major contributors of cost (number of chemotherapy cycles; number of advanced imaging studies) compared with the control arm.
Interventions
- BEHAVIORAL Enhanced Care (intervention group and comparison group)
- BEHAVIORAL Usual care (routine chemotherapy cycles and imaging studies)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01924416
The ClinicalTrials.gov registry entry for NCT01924416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Care (intervention group and comparison group) is the first listed.
NCT01924416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01924416 about?
NCT01924416 is a clinical study titled "Lung Cancer Information Study (LCIS-R01)". The primary specific aim is to test the hypothesis that use of a decision aid to enhance informed, shared decision making coupled with quality of life assessment in patients with advanced lung cancer receiving first-, second-, or third-line therapy will lead to a reduction in two major contributors ...
What is the current status of trial NCT01924416?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2012-09. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01924416?
The interventions under investigation include: Enhanced Care (intervention group and comparison group) (BEHAVIORAL), Usual care (routine chemotherapy cycles and imaging studies) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01924416?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.